Inovio Pharmaceuticals, Inc. - Product Pipeline Review

Global Markets Direct’s, ‘Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Inovio Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Inovio Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Inovio Pharmaceuticals, Inc.

The report provides overview of Inovio Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Inovio Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Inovio Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Inovio Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Inovio Pharmaceuticals, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Inovio Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 6

Inovio Pharmaceuticals, Inc. Snapshot 7

Inovio Pharmaceuticals, Inc. Overview 7 ...

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 6

Inovio Pharmaceuticals, Inc. Snapshot 7

Inovio Pharmaceuticals, Inc. Overview 7

Key Information 7

Key Facts 7

Inovio Pharmaceuticals, Inc. - Research and Development Overview 8

Key Therapeutic Areas 8

Inovio Pharmaceuticals, Inc. - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Pipeline Products - Out-Licensed Products 15

Out-Licensed Products/Combination Treatment Modalities 16

Inovio Pharmaceuticals, Inc. - Pipeline Products Glance 17

Inovio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 17

Phase II Products/Combination Treatment Modalities 17

Phase I Products/Combination Treatment Modalities 18

Inovio Pharmaceuticals, Inc. - Early Stage Pipeline Products 19

Preclinical Products/Combination Treatment Modalities 19

Inovio Pharmaceuticals, Inc. - Drug Profiles 20

VGX-3100 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

INO-8000 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

FVH-1 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

influenza [strain A/H3N2] vaccine 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

INO-1400 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

INO-3106 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

INO-3510 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

INO-4212 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

INO-4500 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

INO-5150 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

PENNVAX-B 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

PENNVAX-G 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

PENNVAX-GP 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

VGX-3400X 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

VRC-01 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

chikungunya vaccine 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Clostridium difficile vaccine 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

dengue [serotypes 1, 2, 3, 4] (tetravalent) vaccine 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

Gene Therapy for Ebola Virus Infections 41

Product Description 41

Mechanism of Action 41

R&D Progress 41

influenza [strain A/H7N9] vaccine 42

Product Description 42

Mechanism of Action 42

R&D Progress 42

INO-5400 43

Product Description 43

Mechanism of Action 43

R&D Progress 43

MAV-12 44

Product Description 44

Mechanism of Action 44

R&D Progress 44

Monoclonal Antibodies to Inhibit Tyrosinase for Oncology and Immunology 45

Product Description 45

Mechanism of Action 45

R&D Progress 45

Monoclonal Antibody for Chikungunya 46

Product Description 46

Mechanism of Action 46

R&D Progress 46

respiratory syncytial virus vaccine 47

Product Description 47

Mechanism of Action 47

R&D Progress 47

RSQ-15 48

Product Description 48

Mechanism of Action 48

R&D Progress 48

Vaccine for Cancer 49

Product Description 49

Mechanism of Action 49

R&D Progress 49

Vaccines for Neurological Disorders 50

Product Description 50

Mechanism of Action 50

R&D Progress 50

Inovio Pharmaceuticals, Inc. - Pipeline Analysis 51

Inovio Pharmaceuticals, Inc. - Pipeline Products by Target 51

Inovio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 53

Inovio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 54

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 55

Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates 56

Inovio Pharmaceuticals, Inc. - Dormant Projects 66

Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products 67

Discontinued Pipeline Product Profiles 67

mifepristone 67

VGX-410C 67

Inovio Pharmaceuticals, Inc. - Company Statement 68

Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries 71

Head Office 71

Other Locations & Subsidiaries 71

Appendix 72

Methodology 72

Coverage 72

Secondary Research 72

Primary Research 72

Expert Panel Validation 72

Contact Us 72

Disclaimer 73

List of Tables

List of Tables

Inovio Pharmaceuticals, Inc., Key Information 7

Inovio Pharmaceuticals, Inc., Key Facts 7

Inovio Pharmaceuticals, Inc. - Pipeline by Indication, 2016 9

Inovio ...

List of Tables

Inovio Pharmaceuticals, Inc., Key Information 7

Inovio Pharmaceuticals, Inc., Key Facts 7

Inovio Pharmaceuticals, Inc. - Pipeline by Indication, 2016 9

Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 11

Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 12

Inovio Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016 13

Inovio Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 14

Inovio Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016 15

Inovio Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 16

Inovio Pharmaceuticals, Inc. - Phase II, 2016 17

Inovio Pharmaceuticals, Inc. - Phase I, 2016 18

Inovio Pharmaceuticals, Inc. - Preclinical, 2016 19

Inovio Pharmaceuticals, Inc. - Pipeline by Target, 2016 52

Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 53

Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 54

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 55

Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 56

Inovio Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 66

Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 67

Inovio Pharmaceuticals, Inc., Subsidiaries 71

List of Figures

List of Figures

Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016 9

Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 11 ...

List of Figures

Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016 9

Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 11

Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 12

Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016 51

Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 53

Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 54

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 55

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports